Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types
Amgen (NASDAQ:AMGN) today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American ...
Amgen (NASDAQ:AMGN) today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American ...
Amber Hill spent 14 years as a medical researcher. She didn’t mind the work, but there was one thing she ...
Pitch N Deal’s new blog is the ultimate destination for investors and startups, bringing together inspiring interviews, event insights, and motivational stories all in one place. Discover the journeys of successful investors & entrepreneurs and gain valuable lessons that can propel your own ventures forward. Join us as we gather real-life stories and interviews, laying the foundation for an upcoming book that captures the essence of the investors & entrepreneurial success.
© 2024 Pitch N Deal. All rights reserved.